Attovia Therapeutics, Inc.

Attovia Therapeutics, Inc.

ATTO
Attovia Therapeutics, Inc.US flagNASDAQ
13.89
USD
+0.16
- -
634.10MMarket Cap

Income Statement (USD)

2024 Y
2025 Y
As of date
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
1
+ Sales & Services Revenue
- -
1
- Cost of Revenue
- -
- -
+ Cost of Goods & Services
- -
- -
Gross Profit
- -
- -
+ Other Operating Income
- -
-1
- Operating Expenses
42
69
+ Selling, General & Admin
8
14
+ Research & Development
34
54
+ Other Operating Expense
- -
- -
Operating Income (Loss)
-42
-67
- Non-Operating (Income) Loss
-2
-7
+ Interest Expense, Net
-3
-7
+ Interest Expense
- -
- -
- Interest Income
3
7
+ Other Non-Op (Income) Loss
2
- -
Pretax Income
-40
-61
- Income Tax Expense (Benefit)
- -
- -
- (Income) Loss from Affiliates
- -
- -
Income (Loss) from Cont Ops
-40
-61
- Net Extraordinary Losses (Gains)
- -
- -
+ Discontinued Operations
- -
- -
+ Extraord. & Accounting Changes
- -
- -
Income (Loss) Incl. MI
-40
-61
- Minority Interest
- -
- -
Net Income, GAAP
-40
-61
- Preferred Dividends
- -
- -
- Other Adjustments
- -
- -
Net Income Avail to Common, GAAP
-40
-61
EBIT
-42
-67
EBITDA
-41
-66
EBITDA Margin (%)
- -
-4,915.19
EBITA
-42
-67
Gross Margin (%)
- -
100
Operating Margin (%)
- -
-4,974.74
Profit Margin (%)
- -
-4,490.89
Sales per Employee
- -
- -
Dividend per Share
- -
- -
Depreciation Expense
- -
1
Basic Weighted Avg Shares
26
25
Basic EPS, GAAP
-1.55
-2.38
Basic EPS from Cont Ops
-1.55
-2.38
Diluted Weighted Avg Shares
26
25
Diluted EPS, GAAP
-1.55
-2.38
Diluted EPS from Cont Ops
-1.55
-2.38

Balance Sheet (USD)

2024 Y
2025 Y
As of date
12/31/2024
12/31/2025
Total Current Assets
72
156
+ Cash, Cash Equivalents & STI
69
152
+ Cash & Cash Equivalents
31
40
+ ST Investments
39
112
+ Accounts & Notes Receiv
- -
1
+ Accounts Receivable, Net
- -
- -
+ Notes Receivable, Net
- -
- -
+ Loans Receivable, Net
- -
- -
+ Other Receivable, Net
- -
1
+ Inventories
- -
- -
+ Raw Materials
- -
- -
+ Work In Process
- -
- -
+ Finished Goods
- -
- -
+ Inventory Adjustments
- -
- -
+ Other Inventory
- -
- -
+ Other ST Assets
3
3
+ Misc ST Assets
- -
- -
+ Prepaid Expenses
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
+ ST Assets Held-for-Sale
- -
- -
+ ST Deferred Tax Assets
- -
- -
Total Noncurrent Assets
4
10
+ Property, Plant & Equip, Net
3
8
+ Property, Plant & Equip
4
9
- Accumulated Depreciation
- -
1
+ LT Investments & Receivables
- -
- -
+ LT Investments
- -
- -
+ LT Receivables
- -
- -
+ Other LT Assets
1
2
+ Total Intangible Assets
- -
- -
+ Goodwill
- -
- -
+ Other Intangible Assets
- -
- -
+ LT Deferred Tax Assets
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
+ Misc LT Assets
1
2
Total Assets
77
166
+ Payables & Accruals
6
6
+ Accounts Payable
4
4
+ Accrued Taxes
- -
- -
+ Interest & Dividends Payable
- -
- -
+ Other Payables & Accruals
2
2
+ ST Debt
- -
2
+ ST Borrowings
- -
- -
+ ST Finance Leases
- -
2
+ Other ST Liabilities
2
4
+ Deferred Revenue
- -
- -
+ Derivatives & Hedging
- -
- -
+ Deferred Tax Liabilities
- -
- -
+ Misc ST Liabilities
2
3
Total Current Liabilities
8
11
+ LT Debt
- -
3
+ LT Borrowings
- -
- -
+ LT Finance Leases
- -
3
+ Other LT Liabilities
116
259
+ Accrued Liabilities
- -
- -
+ Pension Liabilities
- -
- -
+ Deferred Revenue
- -
- -
+ Deferred Tax Liabilities
- -
- -
+ Derivatives & Hedging
- -
- -
+ Misc LT Liabilities
116
259
Total Noncurrent Liabilities
116
262
Total Liabilities
124
273
+ Preferred Equity and Hybrid Capital
- -
- -
+ Share Capital & APIC
3
3
+ Common Stock
- -
- -
+ Additional Paid in Capital
3
3
- Treasury Stock
- -
- -
+ Retained Earnings
-50
-111
+ Other Equity
- -
- -
Equity Before Minority Interest
-47
-107
+ Minority/Non Controlling Interest
- -
- -
Total Equity
-47
-107
Total Liabilities & Equity
77
166
Shares Outstanding
43
43
Number of Employees
- -
- -
Capital Leases - Total
- -
5
Net Debt
-31
-40
Net Debt to Equity
65.42
37.41
Tangible Common Equity Ratio
-61.04
-64.76
Current Ratio
9.39
14.2
Cash Conversion Cycle
- -
- -

Cash Flow Statement (USD)

2024 Y
2025 Y
As of date
12/31/2024
12/31/2025
+ Net Income
-40
-61
+ Depreciation & Amortization
- -
1
+ Non-Cash Items
3
- -
+ Stock-Based Compensation
1
2
+ Deferred Income Taxes
- -
- -
+ Asset Impairment Charge
- -
- -
+ Other Non-Cash Adj
2
-2
+ Chg in Non-Cash Work Cap
2
- -
+ (Inc) Dec in Accts Receiv
- -
- -
+ (Inc) Dec in Inventories
- -
- -
+ (Inc) Dec in Prepaid Assets
-2
- -
+ Inc (Dec) in Accts Payable
4
1
+ Inc (Dec) in Other
-1
-1
+ Net Cash From Disc Ops
- -
- -
Cash from Operating Activities
-35
-59
+ Change in Fixed & Intang
- -
- -
+ Disp in Fixed & Intang
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
+ Disp of Intangible Assets
- -
- -
+ Acq of Fixed & Intang
-2
-2
+ Acq of Fixed Prod Assets
-2
-2
+ Acq of Intangible Assets
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
+ Increase in Capital Stock
- -
- -
+ Decrease in Capital Stock
- -
- -
+ Net Change in LT Investment
-38
-71
+ Dec in LT Investment
8
151
+ Inc in LT Investment
-46
-222
+ Net Cash From Acq & Div
- -
- -
+ Cash from Divestitures
- -
- -
+ Cash for Acq of Subs
- -
- -
+ Cash for JVs
- -
- -
+ Other Investing Activities
- -
- -
+ Net Cash From Disc Ops
- -
- -
Cash from Investing Activities
-40
-73
+ Dividends Paid
- -
- -
+ Net Cash From Debt
- -
- -
+ Cash From Debt
- -
- -
+ Repayments of Debt
- -
- -
+ Other Financing Activities
83
142
+ Net Cash From Disc Ops
- -
- -
Cash from Financing Activities
83
142
Effect of Foreign Exchange Rates
- -
- -
Net Changes in Cash
8
9
EBITDA
-41
-66
EBITDA Margin (%)
- -
-4,915.19
Free Cash Flow
-37
-62
Net Cash Paid for Acquisitions
- -
- -
Free Cash Flow to Firm
- -
- -
Free Cash Flow to Equity
- -
-62
Free Cash Flow per Basic Share
-1.43
-2.42
Price/Free Cash Flow
- -
- -
Cash Flow to Net Income
0.88
0.98
Capital Expenditures
-2
-2